Neogen Corporation (NEOG) P/E Ratio History
Historical price-to-earnings valuation from 1996 to 2024
Loading P/E history...
NEOG Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Neogen Corporation (NEOG) trades at a price-to-earnings ratio of -1.8x, with a stock price of $9.25 and trailing twelve-month earnings per share of $-2.77.
The current P/E is 101% below its 5-year average of 226.2x. Over the past five years, NEOG's P/E has ranged from a low of 49.4x to a high of 2387.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, NEOG trades at a 108% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, NEOG trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NEOG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
NEOG P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $45B | 43.7 | 3.06 | +23% | |
| $613M | 9.9 | 0.31Best | +777%Best | |
| $2B | 3.6Lowest | - | +307% | |
| $7B | 9.2 | - | +143% | |
| $4B | 30.8 | 3.53 | -16% | |
| $24B | 49.9 | - | -40% | |
| $7B | 6.0 | 0.85 | +0% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
NEOG Historical P/E Data (1996–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q3 | $17.19 | $0.01 | 2387.5x | +3272% | |
| FY2024 Q2 | $16.97 | $0.05 | 312.5x | +341% | |
| FY2023 Q3 | $17.69 | $0.04 | 468.0x | +561% | |
| FY2023 Q2 | Wed Nov 30 2022 00:00:00 GM | $16.56 | $0.05 | 329.2x | +365% |
| FY2023 Q1 | Wed Aug 31 2022 00:00:00 GM | $20.90 | $0.34 | 61.4x | -13% |
| FY2022 Q4 | $26.46 | $0.45 | 58.8x | -17% | |
| FY2022 Q3 | Mon Feb 28 2022 00:00:00 GM | $35.70 | $0.46 | 77.6x | +10% |
| FY2022 Q2 | $40.13 | $0.53 | 75.7x | +7% | |
| FY2022 Q1 | $43.78 | $0.58 | 75.5x | +7% | |
| FY2021 Q4 | Mon May 31 2021 00:00:00 GM | $46.15 | $0.57 | 81.0x | +14% |
| FY2021 Q3 | Sun Feb 28 2021 00:00:00 GM | $40.96 | $0.57 | 71.9x | +1% |
| FY2021 Q2 | Mon Nov 30 2020 00:00:00 GM | $37.11 | $0.57 | 65.1x | -8% |
Average P/E for displayed period: 70.8x
See NEOG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NEOG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NEOG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNEOG — Frequently Asked Questions
Quick answers to the most common questions about buying NEOG stock.
Is NEOG stock overvalued or undervalued?
NEOG trades at -1.8x P/E, below its 5-year average of 226.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does NEOG's valuation compare to peers?
Neogen Corporation P/E of -1.8x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is NEOG's PEG ratio?
NEOG PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1996-2024.